Radiation Therapy for Non-Melanoma Skin Cancer

 

A machine is used to target high-energy rays specifically at the cancerous area. Radiation therapy (also called radiotherapy) is not a common treatment for skin cancer, but may be used in certain instances, such as when the cancer is in an area that makes surgery difficult or when the patient is not a good candidate for surgery because of age or health reasons. This treatment may also be used in very advanced cases or when skin cancer recurs after initial surgical treatment.

The way in which radiation therapy is delivered depends on the extent and type of non-melanoma skin cancer that is being treated:

  • External radiation therapy is delivered by a machine that aims radiation beams directly to the cancer site.
  • Internal radiation therapy is given by sealing radioactive medicine in a small device, such as a needle, “seed,” wire, or catheter (thin, hollow, flexible tubing), that is placed directly into or close to the site of the cancer.

Side effects from radiation therapy are common but usually temporary. They may include soreness, redness, or blistering at the radiation site, or hair thinning or loss.

This content has been reviewed and approved by Myo Thant, MD.

This content was last modified on February 21, 2008 .
Latest Cancer News
Vaccine Against HPV-16 Effective for Vulvar Intraepithelial Neoplasia

November 6, 2009 — Researchers from the Netherlands have reported that vaccination with synthetic long-peptides against human papillomavirus (HPV)-16 was effective in treating vulvar intraepithelial neoplasia (VIN). The details of this study were published in the November 5, 2009 issue of the New England Journal of Medicine.

Small HER2-positive Breast Cancers Have a Higher Risk of Recurrence

November 6, 2009 — Researchers from the M. D. Anderson Cancer Center and the University of Milan, Italy, have reported that women with Stage T1a,b, N0M0 HER2-positive breast cancers have a have a high recurrence rate without the administration of adjuvant chemotherapy or Herceptin® (trastuzumab). These data suggest that these women should be treated with Herceptin®-based adjuvant chemotherapy. The details of these two studies appeared in early online publications on November 2, 2009 in the Journal of Clinical Oncology.

Alcohol May Reduce Risk of Thyroid Cancer

November 6, 2009 — Researchers affiliated with the NIH-AARP Diet and Health Study have reported that alcohol intake may reduce the risk of thyroid cancer. The details of this study appeared in the November 4, 2009 issue of the British Journal of Cancer.

Select news items provided by Reuters Health